Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis

Jiaxin Liao,Yuqing Zhang,Minying Huang,Zhijun Liang,Yao Gong,Ben Liu,Yuling Li,Jiaxi Chen,Wei Wu,Zunnan Huang,Jing Sun
DOI: https://doi.org/10.1016/j.bioorg.2023.106837
IF: 5.307
2023-11-01
Bioorganic Chemistry
Abstract:Immunotherapy has been shown to provide superior antitumor efficacy by activating the innate immune system to recognize, attack and eliminate tumor cells without seriously harming normal cells. Herein, we designed and synthesized three new cyclometalated iridium(III) complexes (Ir1, Ir2, Ir3) then evaluated their antitumor activity. When co-incubated with HepG2 cells, the complex Ir1 localized in the lysosome, where it induced paraptosis and endoplasmic reticulum stress (ER stress). Notably, Ir1 also induced immunogenic cell death (ICD), promoted dendritic cell maturation that enhanced effector T cell chemotaxis to tumor tissues, down-regulated proportions of immunosuppressive regulatory T cells within tumor tissues and triggered activation of antitumor immunity throughout the body. To date, Ir1 is the first reported iridium(III) complex-based paraptosis inducer to successfully induce tumor cell ICD. Furthermore, Ir1 induced ICD of HepG2 cells without affecting cell cycle or reactive oxygen species levels.
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?